| Authors: |
Rosen RL; Massachusetts General Hospital/Harvard Medical School, Boston, MA., Lee JW; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA., Gareen IF; ECOG-ACRIN Biostatistics Center, Brown University, Boston, MA., Herman BA; ECOG-ACRIN Biostatistics Center, Brown University, Boston, MA., Fenech A; University of Delaware, Newark, DE., Kircher S; Northwestern University, Evanston, IL., Carlos RC; Columbia University, New York, NY., Kumar SK; Mayo Clinic, Rochester, MN., Mayer IA; Vanderbilt University/Ingram Cancer Center, Nashville, TN., Saba NF; Emory University/Winship Cancer Institute, Atlanta, GA., Fenske TS; Medical College of WisconsinMilwaukee, WI., Neal JW; Stanford Cancer Institute, Palo Alto, CA., Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC., Hodi FS; Dana-Farber/Harvard Cancer Center, Boston, MA., Kyriakopoulos CE; University of Wisconsin Hospital and Clinics, Madison, WI., Tempany-Afdhal CM; Brigham and Women's Hospital, Boston, MA., Shanafelt TD; Stanford Cancer Institute, Palo Alto, CA., Wagner LI; University of North Carolina, Chapel Hill, NC., Ostroff JS; Memorial Sloan Kettering Cancer Center, New York, NY., Park ER; Massachusetts General Hospital Cancer Center, Boston, MA. |
